
Friday, May 18, 2018 6:22:01 PM

Liked By
Spread the love. Be the first to like this post!
Recent CTSO News
- Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation • GlobeNewswire Inc. • 03/29/2023 12:30:00 PM
- CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM) • GlobeNewswire Inc. • 03/22/2023 12:09:06 PM
- CytoSorbents Comments on Bank Exposure and Diversified Cash Position • GlobeNewswire Inc. • 03/14/2023 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/09/2023 10:22:30 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/09/2023 09:49:32 PM
- CytoSorbents Reports Fourth Quarter and Full Year 2022 Results • GlobeNewswire Inc. • 03/09/2023 09:15:00 PM
- New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time • GlobeNewswire Inc. • 03/07/2023 12:00:00 PM
- CytoSorbents to Present at the Cowen 43rd Annual Health Care Conference • PR Newswire (US) • 02/27/2023 12:00:00 PM
- CytoSorbents to Report Fiscal 2022 Operating and Financial Results • PR Newswire (US) • 02/24/2023 12:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:52:08 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/08/2023 11:05:28 AM
- CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue • PR Newswire (US) • 01/31/2023 12:15:00 PM
- CytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T Trial • PR Newswire (US) • 01/23/2023 12:00:00 PM
- CytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs • PR Newswire (US) • 01/17/2023 12:00:00 PM
- CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement • PR Newswire (US) • 12/29/2022 12:00:00 PM
- Healthcare Microcap Pops On DSMB Recommendation • AllPennyStocks.com • 12/21/2022 08:40:00 PM
- CytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without Modifications • PR Newswire (US) • 12/21/2022 12:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/09/2022 09:32:42 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/08/2022 09:31:39 PM
- Dawson James Keeps Their Buy Rating on Cytosorbents (CTSO) • TipRanks • 11/20/2022 01:25:15 PM
- CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled • PR Newswire (US) • 11/14/2022 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/03/2022 09:24:55 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/03/2022 09:17:19 PM
- CytoSorbents Reports Third Quarter 2022 Financial and Operational Results • PR Newswire (US) • 11/03/2022 08:15:00 PM
- 'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals • PR Newswire (US) • 11/02/2022 11:10:00 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • TLSA • Mar 31, 2023 7:07 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM